课题基金 / 基金详情

Extracellular Redox Signaling in mammary tumor-fibroblast interactions

Extracellular Redox Signaling in mammary tumor-fibroblast interactions
乳腺肿瘤-成纤维细胞相互作用中的细胞外氧化还原信号传导
批准号:
8614255
负责人:
Melissa Lai Tee Teoh
金额:
$30.43万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-01 至 2018-12-31

项目摘要

项目成果

Melissa Lai Tee Teoh的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结: 对于氧化应激在细胞外环境中的作用,人们的认识存在着根本性的差距 乳腺癌的病因学。我们的长期目标是阐明细胞外氧化还原信号在 促进乳腺肿瘤与成纤维细胞的相互作用。我们的初步数据显示,细胞外膜的丢失 抗氧化酶,细胞外超氧化物歧化酶(EcSOD)是临床乳腺癌中的常见事件 其表达与临床分期呈负相关。我们还观察到,Re- ECSOD在c-Met表达的乳腺癌细胞中的表达对致癌刺激的抑制作用 高表达c-Met配体HGF的乳腺成纤维细胞。这些发现让我们得出了这样的假设 ECSOD的表达通过氧化介导促进乳腺癌的进展和转移 肿瘤-成纤维细胞的相互作用,通过激活HGF/c-Met轴。这项研究的目标是确定 乳腺癌中EcSOD表达失控的机制及其后果 在促进HGF/c-R的过程中,EcSOD的表达缺失(以及由此导致的细胞外氧化应激的增加) Met介导的肿瘤发生。我们将首先确定异常的DNA启动子甲基化在 调控临床乳腺癌组织中EcSOD基因沉默。接下来,我们将测试一个新的想法,即氧化 肿瘤微环境是促进HGF/c-Met信号转导的关键因素之一。一切都很好 已证实肝细胞生长因子(HGF)通常由癌症相关者过度表达和分泌 成纤维细胞。这种旁分泌因子激活其在癌细胞表面的受体c-Met。在 第二个目标,我们将确定EcSOD的缺失是否促进了正常人的致瘤转化 HGF高表达乳腺成纤维细胞诱导的乳腺上皮细胞相反,我们将评估是否 ECSOD在乳腺癌细胞中的重新表达将减弱成纤维细胞诱导的致癌刺激。 衍生的HGF。我们将进一步研究NADPH氧化酶是否会对血浆产生氧化应激 膜参与了HGF/c-Met的活化。我们将利用三维共文化模型,包括 癌细胞和它们的致癌“伙伴”--成纤维细胞。除了确定 成纤维细胞对癌细胞的致瘤刺激作用,我们还将考察癌细胞如何 相互改变成纤维细胞的表型。接下来,我们将研究EcSOD对肿瘤生长的影响 使用同基因小鼠模型和使用AFP基因的c-Met表达乳腺癌细胞的转移 原位肿瘤-成纤维细胞模型。总体而言,我们的多管齐下的研究将利用过度表达、下调、 失活突变蛋白表达、药物模拟超氧化物歧化酶和化学抑制方法 验证细胞外氧化应激在促进乳腺癌进展和转移中的作用。 积极的结果将有助于扩大我们对细胞外氧化应激在燃料中的作用的理解 癌症上皮-成纤维细胞的相互作用,朝着新的治疗干预措施的发展。
英文摘要
Project Summary: There is a fundamental gap in knowledge of the role of oxidative stress in the extracellular environment in the etiology of breast cancer. Our long term goal is to elucidate the role of extracellular redox signaling in promoting mammary tumor-fibroblast interactions. Our preliminary data suggest that loss of an extracellular antioxidant enzyme, extracellular superoxide dismutase (EcSOD) is a frequent event in clinical breast cancer tissue and there is an inverse correlation between its expression and clinical stage. We also observed that re- expression of EcSOD in c-Met expressing breast cancer cells strongly attenuated oncogenic stimulation by mammary fibroblasts that overexpress the c-Met ligand, HGF. These findings led us to our hypothesis that loss of EcSOD expression contributes to breast cancer progression and metastasis through oxidative-mediated tumor-fibroblast interactions, via activating the HGF/c-Met axis. The objectives of this study are to identify the mechanisms involved in deregulating the expression of EcSOD in breast cancers and the consequences of the loss of EcSOD expression (and the resulting increase in extracellular oxidative stress) in promoting HGF/c- Met-mediated oncogenesis. We will first determine the involvement of aberrant DNA promoter methylation in regulating EcSOD gene silencing in clinical breast cancer tissues. Next, we will test a novel idea that oxidative tumor microenvironment is one of the key factors that promotes HGF/c-Met signaling. It has been well established that Hepatocyte growth factor (HGF) is often overexpressed and secreted by cancer-associated fibroblasts. This paracrine factor activates its receptor, c-Met on the surface of cancer epithelial cells. In the second aim, we will determine whether loss of EcSOD promotes tumorigenic transformation of normal mammary epithelial cells by HGF-overexpressing mammary fibroblasts. Conversely, we will evaluate whether re-expression of EcSOD in breast cancer cells will attenuate oncogenic stimulation induced by fibroblast- derived HGF. We will further examine whether NADPH oxidase-generated oxidative stress on the plasma membrane is involved in HGF/c-Met activation. We will utilize a 3-dimensional co-culture model that includes both the cancer epithelial cells and their oncogenic 'partner', fibroblasts. In addition to determining the tumorigenic stimulation of fibroblasts on cancer epithelial cells, we will also examine how cancer cells reciprocally alter the phenotype of fibroblasts. We will next investigate the effects of EcSOD on tumor growth and metastasis of c-Met expressing breast cancer cells using a syngeneic mouse model as well as using an orthotopic tumor-fibroblast model. Overall, our multi-pronged study will utilize overexpression, knock-down, inactive mutant protein expression, pharmaceutical SOD mimetic and chemical inhibition approaches to validate the role of extracellular oxidative stress in promoting progression and metastasis of breast cancer. Positive outcome will help in expanding our understanding of the role of extracellular oxidative stress in fueling cancer epithelial-fibroblast interactions, towards development of novel therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extracellular Redox Signaling in mammary tumor-fibroblast interactions
Extracellular Redox Signaling in mammary tumor-fibroblast interactions
Extracellular Redox Signaling in mammary tumor-fibroblast interactions
海外基金